Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
33 pending office actions • 24 clients • 32 examiners • 28 art units • 0 of 33 (0%) have an AI response strategy ready
Acuity Law Group, P.C. practices in Biotechnology & Pharmaceuticals and has 32 pending office actions. Its record covers 1925 career applications, providing a broad base for interpreting the reported results.
The resolved allowance rate is 79.98%, and applications reaching allowance have averaged 4.21 office actions. The profile reflects a substantial biotechnology and pharmaceutical practice, with resolved matters that generally require repeated examination engagement before allowance.
Based on the USPTO statutory response window for each pending office action. 10 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 10 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 4 (12%) |
| §103 only | 9 (27%) |
| §112 only | 1 (3%) |
| Double-patenting only | 1 (3%) |
| Double-patenting + other | 2 (6%) |
| Multi-statute (no §101) | 15 (45%) |
| No statute on record | 1 (3%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KIM, YOUNG J | 2 | 64.8% | +18.2% |
| SONG, HOSUK | 1 | 94.6% | +3.0% |
| HAGHIGHATIAN, MINA | 1 | 46.0% | +39.4% |
| BLUMEL, BENJAMIN P | 1 | 70.7% | +30.6% |
| BALLER, KELSEY E | 1 | 62.5% | +58.6% |
| COLLINS, CYNTHIA E | 1 | 82.2% | +9.0% |
| GEDEON, BRIAN T | 1 | 87.0% | +7.2% |
| DEKARSKE, MADELINE MCGUIRE | 1 | 20.0% | +50.0% |
| GERIDO, DWAN A | 1 | 58.1% | +30.4% |
| CESARE, JOSEPH DAVID | 1 | — | — |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19025540 | MULTI FACTOR AUTHENTICATION | SONG, HOSUK | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18036123 | TEST DEVICE AND TEST PAPER | JARRETT, LORE RAMILLANO | 97d overdue |
| 17999185 | MEK-INHIBITORS FOR THE TREATMENT OR PREVENTION OF CORONAVIRUS INFECTIONS AND/OR COVID-19 CYTOKINE STORM | NESTOR, DONNA MICHELLE | 89d overdue |
| 17617190 | SYSTEM AND METHOD FOR REAL-TIME MULTICOLOR SHORTWAVE INFRARED FLUORESCENCE IMAGING | FAYE, MAMADOU | 74d overdue |
| 17617284 | MICROFLUIDIC CHIP AND MANUFACTURING METHOD THEREFOR | KASS, BENJAMIN JOSEPH | 73d overdue |
| 18262469 | ANALYZER AND METHOD FOR READING DETECTION RESULT OF TEST APPARATUS | TURK, NEIL N | 10d overdue |
| 18261995 | NON-INVASIVE CANCER DETECTION BASED ON DNA METHYLATION CHANGES | KIM, YOUNG J | 13d |
| 18253272 | DETECTING METHYLATION CHANGES IN DNA SAMPLES USING RESTRICTION ENZYMES AND HIGH THROUGHPUT SEQUENCING | VANN-OJUEKAIYE, KENDRA RAYCHELL | 27d |
| 18852335 | METHODS AND COMPOSITIONS FOR POTENTIATION OF A LIGAND | HAGHIGHATIAN, MINA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18261995 | NON-INVASIVE CANCER DETECTION BASED ON DNA METHYLATION CHANGES | KIM, YOUNG J | 13d |
| 18852335 | METHODS AND COMPOSITIONS FOR POTENTIATION OF A LIGAND | HAGHIGHATIAN, MINA | — |
| 18888122 | BIOLOGICAL SAMPLE EXTRACTION BUFFER, AND APPLICATION AND METHOD THEREOF | BLUMEL, BENJAMIN P | — |
| 18749431 | PRESSURE CONTROL SYSTEM, DEVICE AND METHOD FOR OPENING AN AIRWAY | BALLER, KELSEY E | — |
| 18711585 | WHOLE GENOME CPG ANALYSIS | KIM, YOUNG J | — |
| 18693887 | AUTOTAXIN-INHIBITORS | DEKARSKE, MADELINE MCGUIRE | — |
| 18693122 | QUALITY CONTROL SOLUTION AND USE THEREOF | GERIDO, DWAN A | — |
| Art Unit | Apps |
|---|---|
| 1798 | 3 |
| 1681 | 2 |
| 1797 | 2 |
| 1611 | 2 |
| 2435 | 1 |
| 1616 | 1 |
| 1671 | 1 |
| 3785 | 1 |
| 1662 | 1 |
| 3796 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19025540 | MULTI FACTOR AUTHENTICATION | Coronet Cyber Security Ltd. | SONG, HOSUK | 2435 | DP | Final Rejection | — | Pending | Jan 16, 2025 |
| 18852335 | METHODS AND COMPOSITIONS FOR POTENTIATION OF A LIGAND | National Institutes Of Health (Nih), U.S. Dept. Of Health And Human Services (Dhhs), U.S. Government | HAGHIGHATIAN, MINA | 1616 | §102§103§112Other | Non-Final OA | — | Pending | Sep 27, 2024 |
| 18888122 | BIOLOGICAL SAMPLE EXTRACTION BUFFER, AND APPLICATION AND METHOD THEREOF | Leadway (Hk) Limited | BLUMEL, BENJAMIN P | 1671 | §102§103§112 | Non-Final OA | — | Pending | Sep 17, 2024 |
| 18749431 | PRESSURE CONTROL SYSTEM, DEVICE AND METHOD FOR OPENING AN AIRWAY | Ttp PLC | BALLER, KELSEY E | 3785 | §103§112 | Non-Final OA | — | Pending | Jun 20, 2024 |
| 18737469 | METHODS FOR NON-TRANSGENIC GENOME EDITING IN PLANTS | Cellectis | COLLINS, CYNTHIA E | 1662 | §103§112 | Non-Final OA | — | Pending | Jun 07, 2024 |
| 18711585 | WHOLE GENOME CPG ANALYSIS | Nucleix Ltd. | KIM, YOUNG J | 1681 | §103§112 | Non-Final OA | — | Pending | May 18, 2024 |
| 18642557 | BODY-WORN VITAL SIGN MONITOR | Sotera Wireless, Inc. | GEDEON, BRIAN T | 3796 | Other | Non-Final OA | — | Pending | Apr 22, 2024 |
| 18693887 | AUTOTAXIN-INHIBITORS | Universitaet Muenster | DEKARSKE, MADELINE MCGUIRE | 1622 | §101§102§103§112 | Non-Final OA | — | Pending | Mar 20, 2024 |
| 18693122 | QUALITY CONTROL SOLUTION AND USE THEREOF | Leadway (Hk) Limited | GERIDO, DWAN A | 1797 | §102§103§112 | Non-Final OA | — | Pending | Mar 18, 2024 |
| 18290710 | METHOD OF PRODUCING A POPULATION OF IMMUNE CELLS FROM PLURIPOTENT STEM CELLS | Repairon Immuno GmbH | CESARE, JOSEPH DAVID | 1675 | §101§103§112 | Non-Final OA | — | Pending | Jan 19, 2024 |
| 18579268 | FLAVOR COMPOSITION | Planet A Foods GmbH | GWARTNEY, ELIZABETH A | 1759 | §102§112 | Non-Final OA | — | Pending | Jan 12, 2024 |
| 18411732 | METHODS FOR CULTURING CELLS AND KITS AND APPARATUS FOR SAME | C3S2 GmbH | BURKHART, MICHAEL D | 1638 | §103Other | Final Rejection | — | Pending | Jan 12, 2024 |
| 18567733 | NOVEL ANTI-FIBROTIC DRUGS | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) | COPPINS, JANET L | 1628 | §103§112 | Non-Final OA | — | Pending | Dec 06, 2023 |
| 18036054 | DETECTION PLATE HAVING IDENTIFICATION INFORMATION AND ANALYZER FOR READING IDENTIFICATION INFORMATION AND IDENTIFICATION METHOD THEREFOR | Leadway (Hk) Limited | WILLIAMS, JAMEL E | 2855 | §103 | Non-Final OA | — | Pending | Nov 10, 2023 |
| 18559019 | TOPICAL NAPROXEN FORMULATIONS AND THEIR USE | Smartech Topical, Inc. | BELL, SARA ELIZABETH | 1625 | §103§112DP | Non-Final OA | — | Pending | Nov 03, 2023 |
| 18264046 | SOLE USE OF POLYMERSOME ASSOCIATED ADJUVANT FOR STIMULATING AN IMMUNE RESPONSE | Acm Biolabs Pte. Ltd. | YU, DAVID TUYANG | 1635 | §102§103§112 | Non-Final OA | — | Pending | Aug 02, 2023 |
| 18262433 | METHOD OF CHANGING CULTURE MEDIUM OF A CULTURE USING SPINFILTERS | Repairon GmbH | MARTIN, PAUL C | 1653 | §103 | Final Rejection | 19d | Pending | Jul 21, 2023 |
| 18262469 | ANALYZER AND METHOD FOR READING DETECTION RESULT OF TEST APPARATUS | Leadway (Hk) Limited | TURK, NEIL N | 1798 | §103§112 | Final Rejection | 10d overdue | Pending | Jul 21, 2023 |
| 18261995 | NON-INVASIVE CANCER DETECTION BASED ON DNA METHYLATION CHANGES | Nucleix Ltd. | KIM, YOUNG J | 1681 | §101§103§112 | Final Rejection | 13d | Pending | Jul 18, 2023 |
| 18253272 | DETECTING METHYLATION CHANGES IN DNA SAMPLES USING RESTRICTION ENZYMES AND HIGH THROUGHPUT SEQUENCING | Nucleix Ltd. | VANN-OJUEKAIYE, KENDRA RAYCHELL | 1682 | §101§103 | Final Rejection | 27d | Pending | May 17, 2023 |
| 18252489 | LOOP MEDIATED ISOTHERMAL NUCLEIC ACID AMPLIFICATION (LAMP) USING LNA-MODIFIED PRIMERS AND A METAL-BASED COLORIMETRIC METHOD FOR DETECTING AN AMPLIFICATION PRODUCT | Multiplexdx, S.R.O. | PRIEST, AARON A | 1637 | §103 | Final Rejection | 17d overdue | Pending | May 10, 2023 |
| 18036123 | TEST DEVICE AND TEST PAPER | Leadway (Hk) Limited | JARRETT, LORE RAMILLANO | 1797 | §103§112 | Final Rejection | 97d overdue | Pending | May 09, 2023 |
| 18144244 | COMPOSITION AND METHODS FOR SENSITIVE MOLECULAR ANALYSIS | Trust Bio-Sonics, Inc. | LI, JOHN DENNY | 3798 | §112 | Final Rejection | — | Pending | May 08, 2023 |
| 18006136 | A METHOD OF GENERATING AN INDUCED PLURIPOTENT STEM CELL, AN INDUCED PLURIPOTENT STEM CELL AND METHODS OF USING THE INDUCED PLURIPOTENT STEM CELL | Singapore Health Services Pte. Ltd. | MOLOYE, TITILAYO | 1632 | §103§112 | Non-Final OA | — | Pending | Jan 19, 2023 |
| 18092420 | METHODS AND COMPOSITIONS FOR INCREASING EFFICIENCY OF TARGETED GENE MODIFICATION USING OLIGONUCLEOTIDE-MEDIATED GENE REPAIR | Cibus Europe B.V. | BOGGS, RUSSELL T | 1663 | §103Other | Final Rejection | 28d | Pending | Jan 02, 2023 |
| 18003869 | INTERNAL FIXING DEVICE FOR APPARATUS IN TRANSPORT MODE, APPARATUS COMPRISING INTERNAL FIXING DEVICE, AND METHOD FOR REDUCING DAMAGE TO APPARATUS DURING TRANSPORT | Leadway (Hk) Limited | BRAZIN, JACQUELINE | 1798 | §103 | Non-Final OA | — | Pending | Dec 29, 2022 |
| 17999185 | MEK-INHIBITORS FOR THE TREATMENT OR PREVENTION OF CORONAVIRUS INFECTIONS AND/OR COVID-19 CYTOKINE STORM | Atriva Therapeutics GmbH | NESTOR, DONNA MICHELLE | 1627 | §103§112Other | Non-Final OA | 89d overdue | Pending | Nov 17, 2022 |
| 17836455 | SANITIZING ARTICLES FOR LUER ACCESS DEVICES | Cleansite Medical, Inc. | KIPOUROS, HOLLY MICHAELA | 1799 | §102§103§112DP | Non-Final OA | — | Pending | Jun 09, 2022 |
| 17617284 | MICROFLUIDIC CHIP AND MANUFACTURING METHOD THEREFOR | Leadway (Hk) Limited | KASS, BENJAMIN JOSEPH | 1798 | §102§103§112 | Final Rejection | 73d overdue | Pending | Dec 07, 2021 |
| 17617190 | SYSTEM AND METHOD FOR REAL-TIME MULTICOLOR SHORTWAVE INFRARED FLUORESCENCE IMAGING | The Regents of the University of California | FAYE, MAMADOU | 2884 | §103§112 | Non-Final OA | 74d overdue | Pending | Dec 07, 2021 |
| 17276023 | POLYMERSOMES COMPRISING A COVALENTLY BOUND ANTIGEN AS WELL AS METHODS OF MAKING AND USES THEREOF | Acm Biolabs Pte. Ltd. | HOERNER, PAUL ELLSWORTH | 1611 | §103 | Final Rejection | — | Pending | Mar 12, 2021 |
| 17259581 | USE OF BCL6 INHIBITORS FOR TREATING AUTOIMMUNE DISEASES | Teqla Therapeutics Inc. | BAEK, BONG-SOOK | 1611 | §103 | Non-Final OA | — | Pending | Jan 12, 2021 |
| 16622825 | METHODS FOR PURIFYING ENDODERM AND PANCREATIC ENDODERM CELLS DERIVED FROM HUMAN EMBRYONIC STEM CELLS | Miltenyi Biotec B.V. & Co. KG | GONZALES, JOSEPHINE MARIA | 1631 | §103 | Non-Final OA | — | Pending | Dec 13, 2019 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial80.0% of resolved applications prosecuted by Acuity Law Group, P.C. were allowed, across 1,925 applications in USPTO records.
4.21 office actions per allowed application on average.
33 pending office actions as of October 2026, for 24 clients, before 32 examiners in 28 art units.
